YYZ Pharmatech endeavors to enable the next generation of diagnostic & therapeutic medicine by quantitatively describing biology with greater sensitivity than ever before.
YYZ is keen to collaborate with industry partners to address unmet clinical needs, where discovery & measurement approaches are currently limited by sensitivity.
Technology Platform Highlights:
Discover with DPiPSA™ (Database-Driven Proteome Intact Partition Statistical Analysis) - a proprietary bioinformatics platform that generates large scale blood peptide and protein databases, enabling a new paradigm of novel biomarker and target discovery.
Measure with ELiMSA™ (Enzyme Linked Mass Spectrometric Assay) - a patented detection method with industry-leading sensitivity, quantification and reliability to identify any biomolecule, using a combination of enzyme amplification with detection by mass spectrometry.